International Symposium on Pediatric Neurotransmitter Diseases

The 5th International Symposium on Inherited Diseases of the Pancreas.

chronic pancreatitis (ICP), the role of this endogenous trypsin inhibitor has been debated. Rolf Graf presented convincing data that SPINK-1 and monitor peptide not only inhibit trypsin in vitro but also participate in a feedback mechanism regulating trypsinogen secretion from pancreatic acinar cells. Both peptides are upregulated and induced as acute phase proteins during infl ammation, cancer...

First International Symposium on Venereal Diseases and the Treponematoses, 1956.

Dystonia and Dopaminergic Therapy: Rationale Derived from Pediatric Neurotransmitter Diseases

The paucity of literature in pediatric neurotransmitter diseases indicates a gap in our understanding of neurochemistry and the clinical phenomenology. However, the dramatic clinical responses to dopaminergic therapy in dopa-responsive dystonias opened avenues for rationalizing this therapeutic approach in other pediatric neurotransmitter disorders. This chapter aims to link up dopaminergic the...

International Symposium on Hepatotoxicity

This volume is another in the series on Medical Genetics published by the National Foundation-March of Dimes and edited by Daniel Bergsma, M.D. The book is a multiauthored series of monographs with three to fifteen papers in each of the following categories: Cytogenetics and Cell Biology, Clinical Genetics, Biochemical Genetics, Population Genetics, Animal Models of Human Disease, and Future Tr...

Symposium on Cardiovascular Diseases

Syncope is a clinical syndrome characterized by transient loss of consciousness and postural tone that is most often due to temporary and spontaneously self-terminating global cerebral hypoperfusion. A common presenting problem to health care systems, the management of syncope imposes a considerable socioeconomic burden. Clinical guidelines, such as the European Society of Cardiology Guidelines...